Adagio Medical Holdings (ADGM) Preferred Stock Liabilities (2023 - 2024)

Adagio Medical Holdings (ADGM) reported Preferred Stock Liabilities of $91.5 million for Q4 2024, little changed year-over-year from $91.5 million in Q1 2024, and up 5.4% quarter-over-quarter from $86.8 million in Q2 2024.

Adagio Medical Holdings (ADGM) Preferred Stock Liabilities (2023 - 2024) Analysis & Trends

Adagio Medical Holdings (ADGM) has 2 years of Preferred Stock Liabilities data on file, last reported at $91.5 million in Q4 2024.

  • Preferred Stock Liabilities for Q4 2024 came in at $91.5 million, changed 0.0% year-over-year; the trailing twelve-month figure through Dec 2024 was $91.5 million (changed 0.0% YoY), and the FY2024 annual result was $91.5 million, changed 0.0% from the prior year.
  • Preferred Stock Liabilities improved to $91.5 million in Q4 2024 per ADGM's latest filing, from $86.8 million in the prior quarter.
  • Over five years, Preferred Stock Liabilities peaked at $91.5 million in Q3 2023 and troughed at $86.8 million in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn -
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn -
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -
10 Adagio Medical Holdings 15.88 Mn 2.97 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 91.47 Mn
Jun 30, 2024 86.78 Mn
Mar 31, 2024 91.47 Mn
Dec 31, 2023 91.47 Mn
Sep 30, 2023 91.47 Mn